Why is Rossari Biotech falling/rising?

As of 18-Sep, Rossari Biotech Ltd's stock price is currently at 644.55, reflecting an increase of 7.55 or 1.19%. Today's performance indicates a trend reversal as the stock has gained after two consecutive days of decline. Despite this uptick, the stock has underperformed against the benchmark Sensex over the past week and month, with returns of +1.25% and +0.98%, respectively, compared to the Sensex's +1.80% and +2.14%. The stock's delivery volume has significantly decreased, falling by 59.21% against the 5-day average, which may indicate declining investor participation. Additionally, while the company has a low debt-to-equity ratio and a relatively attractive valuation, it has faced consistent underperformance with a -29.04% return over the past year and a decline in profits by -1%.
Broader Market Context: In the broader market, the Sensex has shown a positive trend, gaining 6.24% year-to-date, while Rossari Biotech has experienced a significant decline of -18.17% in the same period. This disparity highlights the stock's struggle to keep pace with market trends, particularly over the last three years, where it has consistently underperformed against the benchmark. The high institutional holdings at 21.32% suggest that more informed investors are involved, yet the stock's flat results and low return on capital employed (ROCE) may contribute to a cautious outlook among investors. Overall, while there is a slight uptick in the stock price today, the long-term performance and market context indicate ongoing challenges for Rossari Biotech.